source
- Bayer's asundexian receives FDA approval for stroke preventionBayer announced that the U.S. Food and Drug Administration has approved its oral anticoagulant asundexian for stroke prevention. The drug is indicated to lower the risk of subsequent stroke in pati…
- London startup raises $60M for degraders aimed at Alzheimer’s protein tauOyster Therapeutics has raised $60 million to develop pills that destroy pathogenic forms of tau, a brain protein implicated in Alzheimer’s disease. The Series A-2 funding was led by life-science v…Endpoints · 1h ago↗ source